Sanofi (United States) (Q333293)

From geokb

company organization in Bridgewater, United States

Language	Label	Description	Also known as
English	Sanofi (United States)	company organization in Bridgewater, United States

Statements

0 references

addresses subject

551

1 reference

https://openalex.org/I4210111804

Management of Diabetes Mellitus and Hypoglycemia

341

1 reference

https://openalex.org/I4210111804

Atopic Dermatitis and Skin Microbiome

339

1 reference

https://openalex.org/I4210111804

Management of Diabetes Mellitus and Cardiovascular Risk

328

1 reference

https://openalex.org/I4210111804

Health Economics and Quality of Life Assessment

297

1 reference

https://openalex.org/I4210111804

Lysosomal Storage Disorders in Human Health and Disease

269

1 reference

https://openalex.org/I4210111804

Allergic Rhinitis and its Impact on Asthma

260

1 reference

https://openalex.org/I4210111804

Influenza Virus Research and Epidemiology

252

1 reference

https://openalex.org/I4210111804

Statistical Methods in Clinical Trials and Drug Development

239

1 reference

https://openalex.org/I4210111804

Therapeutic Antibodies: Development, Engineering, and Applications

199

1 reference

https://openalex.org/I4210111804

Epidemiology and Pathogenesis of Respiratory Viral Infections

198

1 reference

https://openalex.org/I4210111804

Innate Lymphoid Cells in Immunity

185

1 reference

https://openalex.org/I4210111804

Management and Epidemiology of Pneumonia

183

1 reference

https://openalex.org/I4210111804

Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia

181

1 reference

https://openalex.org/I4210111804

Rheumatoid Arthritis Topics

171

1 reference

https://openalex.org/I4210111804

Diagnosis and Treatment of Multiple Myeloma

165

1 reference

https://openalex.org/I4210111804

Immunogenicity of Biosimilar Therapeutics in Drug Development

159

1 reference

https://openalex.org/I4210111804

Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment

156

1 reference

https://openalex.org/I4210111804

Cholesterol-lowering Treatment

155

1 reference

https://openalex.org/I4210111804

Diagnosis and Management of Eosinophilic Esophagitis

151

1 reference

https://openalex.org/I4210111804

Epidemiology and Pathogenesis of Bacterial Meningitis

148

1 reference

https://openalex.org/I4210111804

Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome

143

1 reference

https://openalex.org/I4210111804

Economics of Pharmaceutical Research and Development

142

1 reference

https://openalex.org/I4210111804

Natural Killer Cells in Immunity

137

1 reference

https://openalex.org/I4210111804

Diagnosis and Pathogenesis of Multiple Sclerosis

118

1 reference

https://openalex.org/I4210111804

coordinate location

40°36'3"N, 74°38'53"W

1 reference

https://openalex.org/I4210111804

United States of America

1 reference

https://openalex.org/I4210111804

official website

http://www.sanofi.us/l/us/en/index.jsp

1 reference

https://openalex.org/I4210111804

0 references

Research Organization Registry ID

0 references

is subsidiary of

Sanofi (France)

1 reference

https://openalex.org/I4210111804

Retrieved from "https://geokb.wikibase.cloud/w/index.php?title=Item:Q333293&oldid=1269704"